» Articles » PMID: 20070435

Basic Mechanisms of Neurodegeneration: a Critical Update

Overview
Journal J Cell Mol Med
Date 2010 Jan 15
PMID 20070435
Citations 205
Authors
Affiliations
Soon will be listed here.
Abstract

Neurodegenerative diseases are characterized by progressive dysfunction of specific populations of neurons, determining clinical presentation. Neuronal loss is associated with extra and intracellular accumulation of misfolded proteins, the hallmarks of many neurodegenerative proteinopathies. Major basic processes include abnormal protein dynamics due to deficiency of the ubiquitin-proteosome-autophagy system, oxidative stress and free radical formation, mitochondrial dysfunction, impaired bioenergetics, dysfunction of neurotrophins, 'neuroinflammatory' processes and (secondary) disruptions of neuronal Golgi apparatus and axonal transport. These interrelated mechanisms lead to programmed cell death is a long run over many years. Neurodegenerative disorders are classified according to known genetic mechanisms or to major components of protein deposits, but recent studies showed both overlap and intraindividual diversities between different phenotypes. Synergistic mechanisms between pathological proteins suggest common pathogenic mechanisms. Animal models and other studies have provided insight into the basic neurodegeneration and cell death programs, offering new ways for future prevention/treatment strategies.

Citing Articles

Retina-Targeted 17β-Estradiol by the DHED Prodrug Rescues Visual Function and Actuates Neuroprotective Protein Networks After Optic Nerve Crush in a Rat Model of Surgical Menopause.

Prokai-Tatrai K, Zaman K, Kapic A, Hogan K, Sanchez-Rodriguez G, Silverio A Int J Mol Sci. 2025; 26(5).

PMID: 40076480 PMC: 11899211. DOI: 10.3390/ijms26051846.


From Molecules to Mind: The Critical Role of Chitosan, Collagen, Alginate, and Other Biopolymers in Neuroprotection and Neurodegeneration.

Kruczkowska W, Galeziewska J, Grabowska K, Gromek P, Czajkowska K, Rybicki M Molecules. 2025; 30(5).

PMID: 40076240 PMC: 11901451. DOI: 10.3390/molecules30051017.


Nicotine Influence on Vascular and Neurocognitive Function with In-utero Electronic Cigarette Exposure.

Mills A, Corbin D, Dakhallah D, Dakhlallah D, Chantler P, Olfert I bioRxiv. 2025; .

PMID: 40027767 PMC: 11870428. DOI: 10.1101/2025.02.13.638202.


Editorial: Neuroinflammation and neurodegenerative diseases.

Kumar P, Bhaskar K Front Neurosci. 2025; 19:1561636.

PMID: 40027463 PMC: 11868105. DOI: 10.3389/fnins.2025.1561636.


Multi-targeted benzylpiperidine-isatin hybrids: Design, synthesis, biological and in silico evaluation as monoamine oxidases and acetylcholinesterase inhibitors for neurodegenerative disease therapies.

Negi N, Ayyannan S, Tripathi R J Comput Aided Mol Des. 2025; 39(1):10.

PMID: 40021503 DOI: 10.1007/s10822-025-00588-2.


References
1.
Cuervo A, Stefanis L, Fredenburg R, Lansbury P, Sulzer D . Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004; 305(5688):1292-5. DOI: 10.1126/science.1101738. View

2.
Cookson M . alpha-Synuclein and neuronal cell death. Mol Neurodegener. 2009; 4:9. PMC: 2646729. DOI: 10.1186/1750-1326-4-9. View

3.
Jellinger K . Recent advances in our understanding of neurodegeneration. J Neural Transm (Vienna). 2009; 116(9):1111-62. DOI: 10.1007/s00702-009-0240-y. View

4.
Damiano M, Galvan L, Deglon N, Brouillet E . Mitochondria in Huntington's disease. Biochim Biophys Acta. 2009; 1802(1):52-61. DOI: 10.1016/j.bbadis.2009.07.012. View

5.
Martinet W, Agostinis P, Vanhoecke B, Dewaele M, De Meyer G . Autophagy in disease: a double-edged sword with therapeutic potential. Clin Sci (Lond). 2009; 116(9):697-712. DOI: 10.1042/CS20080508. View